In Ezra Klein and Derk Thompson’s new book Abundance — which maybe you’ve heard of — they tell the story of Katalin Karikó, ...

Ethris, a clinical-stage biotechnology company creating RNA therapeutics and vaccines, and Lonza entered a collaboration to ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...

More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to approve new vaccines and drugs.

The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

Misinformation is nothing new. It has, however, become ubiquitous and, in some cases, more difficult and time-consuming than ...

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). If Pfizer and Moderna can ...

Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks in South and ...

While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...